Evidence map›Paper›PMID 36936953›Full record

ArticleFrontiers in immunology2023

Comparison of NK alloreactivity prediction models based on KIR-MHC interactions in haematopoietic stem cell transplantation.

Adèle Dhuyser, Thomas Remen, Michaël Pérès, Vitalina Chamberlain-Evans, Neda Nemat-Gorgani, Arnaud Campidelli, Sandra Clément, Marie Thérèse Rubio, John Trowsdale, Alice Aarnink and 1 more

Open access · goldFull text read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Adèle DhuyserHistocompatibility Laboratory, Centre Hospitalier Régional Universitaire de Nancy, Nancy, France.
Thomas RemenDirection de la Recherche Clinique et de l'Innovation, Unité de Méthodologie, Datamanagement et Statistiques, Centre Hospitalier Régional Universitaire de Nancy, Nancy, France.
Michaël PérèsHistocompatibility Laboratory, Centre Hospitalier Régional Universitaire de Nancy, Nancy, France.
Vitalina Chamberlain-EvansDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.
Neda Nemat-GorganiDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.
Arnaud CampidelliDepartment of Hematology, Centre Hospitalier Régional Universitaire de Nancy, Nancy, France.
Sandra ClémentHistocompatibility Laboratory, Centre Hospitalier Régional Universitaire de Nancy, Nancy, France.
Marie Thérèse RubioIngénieurie Moléculaire et Physiopathologie Articulaire, team 6 (IMoPA6), Unité Mixte de Recherche 7365 Centre national de la Recherche Scientifique, Université de Lorraine, Nancy, France.
John TrowsdaleDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.
Alice AarninkHistocompatibility Laboratory, Centre Hospitalier Régional Universitaire de Nancy, Nancy, France.
James TraherneDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.
Centre Hospitalier Régional et Universitaire de Nancy · FRUniversity of Cambridge · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The biological processes underlying NK cell alloreactivity in haematopoietic stem cell transplantation (HSCT) remain unclear. Many different models to predict NK alloreactivity through KIR and MHC genotyping exist, raising ambiguities in its utility and application for clinicians. We assessed 27 predictive models, broadly divided into six categories of alloreactivity prediction: ligand-ligand, receptor-ligand, educational, KIR haplotype-based, KIR matching and KIR allelic polymorphism. The models were applied to 78 NGS-typed donor/recipient pairs undergoing allogeneic HSCT in genoidentical (n=43) or haploidentical (n=35) matchings. Correlations between different predictive models differed widely, suggesting that the choice of the model in predicting NK alloreactivity matters. For example, two broadly used models,

Indexed as

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationHumansKiller Cells, NaturalLigandsReceptors, KIRLigandsReceptors, KIRallogeneic stem cell transplantationalloreactivitydonor selectionHLAKIRMHCnatural killer (NK)prediction

Identifiers

PMID36936953
PMCPMC10017772
OpenAlexW4322773381

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read7
identifiers read2
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.